Why 2026 is the year for Biotechs to expand to Europe
Hosted by Joseph
Registration
Approval Required
Your registration is subject to host approval.
About Event
Thinking about Europe for 2026? Come join us for an hour to hear from and chat with our team of leading UK and German biotech corporate, commercialisation and regulatory specialists as well as Andreas Penk, CEO of European Biopharma Therapeutics. The panel will share their top tips for a successful overseas expansion, the import of pharmaceuticals into Europe, as well as their take on why 2026 is the year to make the most of this opportunity.